Perception of disease burden and treatment satisfaction in patients with ulcerative colitis from outpatient clinics in Spain: UC-LIFE survey

European Journal of Gastroenterology and Hepatology

Volumn 28, Issue 9, 2016, Pages 1056-1064

  Carpio, Daniel ^a   López Sanromán, Antonio ^b   Calvet, Xavier ^c,e,f   Romero, Cristina ^d   Cea Calvo, Luis ^d   Juliá, Berta ^d   Argüelles Arias, Federico ^g  

^a Hospital de Pontevedra   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Medical affairs Merck sharp and Dohme ltd   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^f Parc Tauli Health Corporation   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

disease burden; patient reported outcomes; patients' perception; quality of life; treatment satisfaction; ulcerative colitis

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEFECATION URGENCY; DIARRHEA; EMERGENCY WARD; FATIGUE; FEMALE; FLATULENCE; HOSPITAL; HOSPITAL ADMISSION; HUMAN; INCONTINENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RECTUM HEMORRHAGE; SPAIN; ULCERATIVE COLITIS; ATTITUDE TO HEALTH; CLINICAL TRIAL; COLITIS, ULCERATIVE; COMPLICATION; COST OF ILLNESS; MULTICENTER STUDY; OUTPATIENT; OUTPATIENT DEPARTMENT; PERCEPTION; PSYCHOLOGY; QUALITY OF LIFE; REMISSION; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE FACILITIES; COLITIS, ULCERATIVE; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PATIENT SATISFACTION; PERCEPTION; QUALITY OF LIFE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; SPAIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84973571063     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000658     Document Type: Article

References (33)

1. Ordas I, Eckmann L, Talamini M, Baumgart D, Sandborn W. Ulcerative colitis. Lancet 2012; 380:1606-1619.
2. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med 2011; 365:1713-1725.
3. Feuerstein JD, Cheifetz AS. Ulcerative colitis: epidemiology, diagnosis, and management. Mayo Clin Proc 2014; 89:1553-1563.
4. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142:46. e42-54.e42.
5. Burisch J, Jess T, Martinato M, Lakatos PL. ECCO-EpiCom. The burden of inflammatory bowel disease in Europe. J Crohns Colitis 2013; 7:322-337.
6. Burisch J, Pedersen N, Cuković-Cavka S, Brinar M, Kaimakliotis I, Duricova D, et al. EpiCom-group. East-West gradient in the incidence of inflammatory bowel disease in Europe: The ECCO-EpiCom inception cohort. Gut 2014; 63:588-597.
7. Pajares JM, Gisbert JP. Epidemiology of inflammatory bowel disease in Spain. A systematic review. Rev Esp Enferm Dig 2001; 93:9-14.
8. Rodrigo L, Riestra S, Niño P, Cadahía V, Tojo R, Fuentes D, et al. A population-based study on the incidence of inflammatory bowel disease in Oviedo (Northern Spain). Rev Esp Enferm Dig 2004; 96:296-305.
9. Lucendo AJ, Hervías D, Roncero Ó, Lorente R, Bouhmidi A, Angueira T, et al. Epidemiology and temporal trends (2000-2012) of inflammatory bowel disease in adult patients in a central region of Spain. Eur J Gastroenterol Hepatol 2014; 26:1399-1407.
10. Martín de Carpi J, Rodríguez A, Ramos E, Jiménez S, Martínez-Gómez MJ, Medina E. Increasing incidence of paediatric inflammatory bowel disease in Spain (1996-2009): The SPIRIT registry. Inflamm Bowel Dis 2013; 19:73-80.
11. Loftus EV Jr. A practical perspective on ulcerative colitis: patients needs from aminosalicylate therapies. Inflamm Bowel Dis 2006; 12:1107-1113.
12. Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohns and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohns Colitis 2007; 1:10-20.
13. Gray JR, Leung E, Scales J. Treatment of ulcerative colitis from the patients perspective: A survey of preferences and satisfaction with therapy. Aliment Pharmacol Ther 2009; 29:1114-1120.
14. Rubin DT, Siegel CA, Kane SV, Binion DG, Panaccione R, Dubinsky MC, et al. Impact of ulcerative colitis from patients and physicians perspectives: results from the UC: NORMAL survey. Inflamm Bowel Dis 2009; 15:581-588.
15. Hoivik ML, Moum B, Solberg IC, Cvancarova M, Hoie O, Vatn MH, Bernklev T. IBSEN Study Group. Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study. Inflamm Bowel Dis 2012; 18:1540-1549.
16. Schreiber S, Panés J, Louis E, Holley D, Buch M, Paridaens K. Perception gaps between patients with ulcerative colitis and healthcare professionals: An online survey. BMC Gastroenterol 2012; 12:108.
17. Devlen J, Beusterien K, Yen L, Ahmed A, Cheifetz AS, Moss AC. The burden of inflammatory bowel disease: A patient-reported qualitative analysis and development of a conceptual model. Inflamm Bowel Dis 2014; 20:545-552.
18. Huppertz-Hauss G, Høivik ML, Langholz E, Odes S, Smastuen M, Stockbrugger R, et al. Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis. Inflamm Bowel Dis 2015; 21:337-344.
19. Rubin DT, Dubinsky MC, Panaccione R, Siegel CA, Binion DG, Kane SV, Hopper J. The impact of ulcerative colitis on patients lives compared to other chronic diseases: A patient survey. Dig Dis Sci 2010; 55:1044-1052.
20. Schreiber S, Panés J, Louis E, Holley D, Buch M, Paridaens K. National differences in ulcerative colitis experience and management among patients from five European countries and Canada: An online survey. J Crohns Colitis 2013; 7:497-509.
21. Longobardi T, Bernstein CN. Health care resource utilization in inflammatory bowel disease. Clin Gastroenterol Hepatol 2006; 4: 731-743.
22. Nurmi E, Haapamäki J, Paavilainen E, Rantanen A, Hillilä M, Arkkila P. The burden of inflammatory bowel disease on health care utilization and quality of life. Scand J Gastroenterol 2013; 48:51-57.
23. Aldeguer X, Sicras-Mainar A. Costs of ulcerative colitis from a societal perspective in a regional health care area in Spain: A database study. Gastroenterol Hepatol 2016; 39:9-19.
24. Gibson PR, Vaizey C, Black CM, Nicholls R, Weston AR, Bampton P, et al. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study. J Crohns Colitis 2014; 8:598-606.
25. Cohen R, Skup M, Ozbay AB, Rizzo J, Yang M, Diener M, Chao J. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US. J Med Econ 2015; 18:447-456.
26. Kawalec P, Malinowski KP. Indirect health costs in ulcerative colitis and Crohns disease: A systematic review and meta-Analysis. Expert Rev Pharmacoecon Outcomes Res 2015; 15:253-266.
27. van der Eijk I, Stockbrögger R, Russel M. Influence of quality of care on quality of life in inflammatory bowel disease (IBD): literature review and studies planned. Eur J Intern Med 2000; 11:228-234.
28. van der Eijk I, Vlachonikolis IG, Munkholm P, Nijman J, Bernklev T, Politi P, et al. EC-IBD Study Group. The role of quality of care in healthrelated quality of life in patients with IBD. Inflamm Bowel Dis 2004; 10:392-398.
29. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998; 43:29-32.
30. Lichtiger S, Present DH. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis (comment). Lancet 1990; 336:16-19.
31. Williet N, Sandborn WJ, Peyrin-Biroulet L. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol 2014; 12:1246.e6-1256.e6.
32. Levesque BG, Sandborn WJ, Ruel J, Feagan BG, Sands BE, Colombel JF. Converging goals of treatment of inflammatory bowel disease from clinical trials and practice. Gastroenterology 2015; 148:37. e1-51.e1.
33. Long MD, Kappelman MD, Martin CF, Lewis JD, Mayer L, Kinneer PM, Sandler RS. Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. Inflamm Bowel Dis 2012; 18:2099-2106.